These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 8370706

  • 1. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL, Landolt AM, Jeffreys RV, Diver M, Radcliffe J, White MC.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of insulin-like growth factor 1 on the hormonal product and proliferation of glycoprotein-secreting human pituitary adenomas.
    Atkin SL, Landolt AM, Jeffreys RV, Hipkin L, Radcliffe J, Squire CR, White MC.
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1059-66. PubMed ID: 7691862
    [Abstract] [Full Text] [Related]

  • 3. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
    Rubinek T, Hadani M, Barkai G, Melmed S, Shimon I.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
    [Abstract] [Full Text] [Related]

  • 4. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H, Hadani M, Barkai G, Taylor JE, Culler MD, Shimon I.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [Abstract] [Full Text] [Related]

  • 5. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro.
    Atkin SL, Landolt AM, Foy P, Jeffreys RV, Hipkin L, White MC.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):503-9. PubMed ID: 7525124
    [Abstract] [Full Text] [Related]

  • 6. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [Abstract] [Full Text] [Related]

  • 7. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I, Bácsy E, Varga I, Slowik F, Bálint K, Pásztor E, Czirják S, Gláz E.
    Folia Histochem Cytobiol; 2000 May; 38(3):119-27. PubMed ID: 10970071
    [Abstract] [Full Text] [Related]

  • 8. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.
    Bassetti M, Spada A, Arosio M, Vallar L, Brina M, Giannattasio G.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1093-100. PubMed ID: 3084531
    [Abstract] [Full Text] [Related]

  • 9. The effects of ACTH 1-17 on GH secretion in vitro.
    Ceda GP, Denti L, Valenti G.
    Horm Metab Res; 1987 Aug; 19(8):361-3. PubMed ID: 2822561
    [Abstract] [Full Text] [Related]

  • 10. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 11. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL, Kovacs K, Horvath E, Singer W, Smyth HS.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
    [Abstract] [Full Text] [Related]

  • 12. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC, Chen FW, Hsieh HC.
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [Abstract] [Full Text] [Related]

  • 13. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV, Cano M, Chandler WF, Barkan AL, Horvath E, Kovacs K.
    Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
    [Abstract] [Full Text] [Related]

  • 14. Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.
    Ezzat S, Smyth HS, Ramyar L, Asa SL.
    J Clin Endocrinol Metab; 1995 Mar; 80(3):878-84. PubMed ID: 7883846
    [Abstract] [Full Text] [Related]

  • 15. Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenomas in vitro.
    Webb CB, Thominet JL, Frohman LA.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):417-9. PubMed ID: 6130102
    [Abstract] [Full Text] [Related]

  • 16. Prolactin gene expression in human growth hormone-secreting pituitary adenomas.
    Nagaya T, Seo H, Kuwayama A, Sakurai T, Tsukamoto N, Sugita K, Matsui N.
    J Neurosurg; 1990 Jun; 72(6):879-82. PubMed ID: 2338572
    [Abstract] [Full Text] [Related]

  • 17. Effects of basic fibroblastic growth factor on the function and proliferation of human clinically non-functional pituitary adenomas which secreted glycoprotein hormones in vitro.
    Atkin SL, Jeffreys RV, Foy PM, Hipkin L, Radcliffe J, White MC.
    J Endocrinol; 1995 Jan; 144(1):173-8. PubMed ID: 7534328
    [Abstract] [Full Text] [Related]

  • 18. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH, Koos RD, Sortino MA, Wise PM.
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [Abstract] [Full Text] [Related]

  • 19. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells.
    Cuny T, Zeiller C, Bidlingmaier M, Défilles C, Roche C, Blanchard MP, Theodoropoulou M, Graillon T, Pertuit M, Figarella-Branger D, Enjalbert A, Brue T, Barlier A.
    Endocr Relat Cancer; 2016 Jul; 23(7):509-19. PubMed ID: 27267119
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.